The Chemours Company Statistics

Total Valuation

The Chemours Company has a market cap or net worth of GBP 2.40 billion. The enterprise value is 5.40 billion.

Market Cap	2.40B
Enterprise Value	5.40B

Important Dates

The next estimated earnings date is Friday, February 7, 2025.

Earnings Date	Feb 7, 2025
Ex-Dividend Date	Nov 15, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.41%
Shares Change (QoQ)	-0.28%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	148.26M

Valuation Ratios

The trailing PE ratio is 42.36.

PE Ratio	42.36
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	5.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.17, with an EV/FCF ratio of -10.73.

EV / Earnings	95.28
EV / Sales	1.16
EV / EBITDA	7.17
EV / EBIT	12.56
EV / FCF	-10.73

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 6.51.

Current Ratio	1.73
Quick Ratio	0.87
Debt / Equity	6.51
Debt / EBITDA	4.84
Debt / FCF	-6.36
Interest Coverage	1.88

Financial Efficiency

Return on equity (ROE) is 11.02% and return on invested capital (ROIC) is 6.15%.

Return on Equity (ROE)	11.02%
Return on Assets (ROA)	3.97%
Return on Capital (ROIC)	6.15%
Revenue Per Employee	691,827
Profits Per Employee	9,146
Employee Count	6,200
Asset Turnover	0.75
Inventory Turnover	3.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.36% in the last 52 weeks. The beta is 1.75, so The Chemours Company's price volatility has been higher than the market average.

Beta (5Y)	1.75
52-Week Price Change	-31.36%
50-Day Moving Average	19.23
200-Day Moving Average	21.66
Relative Strength Index (RSI)	62.69
Average Volume (20 Days)	1,393

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.26

Income Statement

In the last 12 months, The Chemours Company had revenue of GBP 4.29 billion and earned 56.70 million in profits. Earnings per share was 0.37.

Revenue	4.29B
Gross Profit	845.33M
Operating Income	364.84M
Pretax Income	36.56M
Net Income	56.70M
EBITDA	586.43M
EBIT	364.84M
Earnings Per Share (EPS)	0.37

Full Income Statement

Balance Sheet

The company has 444.68 million in cash and 3.20 billion in debt, giving a net cash position of -2.76 billion.

Cash & Cash Equivalents	444.68M
Total Debt	3.20B
Net Cash	-2.76B
Net Cash Per Share	n/a
Equity (Book Value)	491.68M
Book Value Per Share	3.28
Working Capital	972.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -215.62 million and capital expenditures -287.99 million, giving a free cash flow of -503.62 million.

Operating Cash Flow	-215.62M
Capital Expenditures	-287.99M
Free Cash Flow	-503.62M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 19.71%, with operating and profit margins of 8.51% and 1.32%.

Gross Margin	19.71%
Operating Margin	8.51%
Pretax Margin	0.85%
Profit Margin	1.32%
EBITDA Margin	13.67%
EBIT Margin	8.51%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.79, which amounts to a dividend yield of 3.96%.

Dividend Per Share	0.79
Dividend Yield	3.96%
Dividend Growth (YoY)	-2.20%
Years of Dividend Growth	n/a
Payout Ratio	196.05%
Buyback Yield	-0.41%
Shareholder Yield	3.55%
Earnings Yield	2.36%
FCF Yield	-20.97%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

The Chemours Company has an Altman Z-Score of 1.86. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.86
Piotroski F-Score	n/a